European Commission still considering EMEA role in device regulation
This article was originally published in RAJ Devices
Executive Summary
Despite stakeholder opposition, the European Commission says it has not ruled out involving the European Medicines Agency in the evaluation of the highest-risk medical devices – though it does not intend to introduce a premarket authorisation requirement for these products1.
You may also be interested in...
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
US FDA scrutiny of DTC genetic tests continues
The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.